Nipent is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Pentostatin.
| Product ID | 0409-0801_8fa82560-cea4-4272-9ae0-c97ac1635c8b |
| NDC | 0409-0801 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nipent |
| Generic Name | Pentostatin |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2007-08-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020122 |
| Labeler Name | Hospira, Inc. |
| Substance Name | PENTOSTATIN |
| Active Ingredient Strength | 2 mg/mL |
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2007-08-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020122 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-08-15 |
| Marketing End Date | 2016-10-01 |
| Marketing Category | NDA |
| Application Number | NDA020122 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-08-15 |
| Ingredient | Strength |
|---|---|
| PENTOSTATIN | 2 mg/mL |
| SPL SET ID: | 674e0e6d-46ed-4868-9196-04019d667716 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-0801 | Nipent | PENTOSTATIN |
| 67457-288 | Pentostatin | Pentostatin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NIPENT 74172705 1730233 Live/Registered |
HOSPIRA, INC. 1991-06-03 |